Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus-Reference-Cited by-同舟云学术

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus

Published:2008 Issue:6 Volume:14 Page:861-871
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Fiel M. Isabel,Agarwal Kaushik,Stanca Carmen,Elhajj Nassim,Kontorinis Nikolas,Thung Swan N.,Schiano Thomas D.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference49 articles.

1. Liver Transplantation for Autoimmune Hepatitis

2. Recurrent autoimmune hepatitis after liver transplantation: Diagnostic criteria, risk factors, and outcome

3. Recurrence of autoimmune liver disease after liver transplantation: A systematic review

4. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation

5. Liver biopsy interpretation for causes of late liver allograft dysfunction

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-mediated rejection in post-liver transplant clinical care: Are we there yet for timely diagnosis and treatment?;Journal of Liver Transplantation;2024-11

2. An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury;Alimentary Pharmacology & Therapeutics;2024-02-07

3. Transplantation Pathology;MacSween's Pathology of the Liver;2024

4. Transplantation;Atlas of Liver Pathology;2024

5. Pathology of Liver, Small Bowel, and Pancreas Transplantation;Gastrointestinal and Liver Pathology;2024